₹ 8.9 Cr
Volume Transacted
(Dec 5, 2024)
59.8 K
Stocks Traded
(Dec 5, 2024)
Last Updated on: Dec 05, 2024
Cipla Ltd
NSE: CIPLA
ISIN
INE059A01026
Last updated on: Dec 05, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Cipla Ltd
NSE: CIPLA
Share Price
₹ 1491.55
-9.55 (-0.64%)
Last updated on: Dec 05, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
04 Dec 2024 | 1501.1 | 1533.2 | 1540.15 | 1492.45 |
03 Dec 2024 | 1534.4 | 1510.45 | 1548.9 | 1509.05 |
02 Dec 2024 | 1508.1 | 1534.4 | 1537.95 | 1504.05 |
29 Nov 2024 | 1534.4 | 1493.95 | 1547.8 | 1492.7 |
28 Nov 2024 | 1492.85 | 1484.6 | 1504.9 | 1474.2 |
27 Nov 2024 | 1491.55 | 1488.95 | 1496.45 | 1469.1 |
26 Nov 2024 | 1493.35 | 1510 | 1513.6 | 1490.3 |
25 Nov 2024 | 1503.4 | 1498.95 | 1507.9 | 1487.65 |
22 Nov 2024 | 1486.3 | 1460.4 | 1496.2 | 1455.85 |
21 Nov 2024 | 1465.65 | 1476.95 | 1477.7 | 1454.7 |
Date | Price (₹) |
---|---|
04 Dec 2024 | 1501.1 |
03 Dec 2024 | 1534.4 |
02 Dec 2024 | 1508.1 |
29 Nov 2024 | 1534.4 |
28 Nov 2024 | 1492.85 |
27 Nov 2024 | 1491.55 |
26 Nov 2024 | 1493.35 |
25 Nov 2024 | 1503.4 |
22 Nov 2024 | 1486.3 |
21 Nov 2024 | 1465.65 |
Company Name | ISIN Code |
---|
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 05 Dec 15:12 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Cipla Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Cipla Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Cipla Ltd drops for fifth straight session
Cipla Ltd fell for a fifth straight session today. The stock is quoting at Rs 1478.6, down...
18 Nov 2024 13:35
Cipla allots 17,064 equity shares under ESOS
Cipla has allotted 17,064 fully paid-up equity shares of Rs 2 each, pursuant to exercise o...
15 Nov 2024 14:19
Cipla's Bengaluru facility gets 8 USFDA observations
The USFDA had conducted an inspection from 7 November to 13 November 2024. The company sai...
14 Nov 2024 14:42
Cipla Ltd soars 1.44%, Gains for third straight session
Cipla Ltd is up for a third straight session in a row. The stock is quoting at Rs 1582.05,...
04 Nov 2024 13:05
Cipla spurts after USFDA classifies Goa unit as VAI
The United States Food and Drug Administration (USFDA) conducted routine current Good Manu...
31 Oct 2024 10:59
Cipla Q2 PAT rises 15% YoY to Rs 1,303 cr
Total revenue from operations grew by 5.58% year on year (YoY) to Rs 7,051.02 crore in the...
29 Oct 2024 15:18
Unlimited trading starting at just Rs. 249*